Lornoxicam With Low Dose Ketamine Versus Pethidine to Control Pain of Acute Renal Colic
Brief Summary
Patients with acute renal colic divided into 2 groups. Group L administered ornoxicam and Group P administered pethidine and VAS was recorded for both groups.
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Completed |
| Study results: | No Results Available |
| Age: | 20 Years to 60 Years (Adult) |
| Enrollment: | 120 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | Jan 02, 2016 | |
|---|---|---|
| Primary Completion: | Jul 17, 2020 | |
| Completion Date: | May 18, 2020 | |
| Study First Posted: | Dec 19, 2018 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Dec 21, 2018 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Prospective, randomized, double blind clinical study including 120 patients with acute renal pain admitted in emergency department. They were randomly assigned to one of two groups using a computer-generated table. Group L received lornoxicam 8 mg IV plus 0.15 mg.kg-1 ketamine and Group P received pethidine 50 mg IV. Parameters were observed at baseline and after 0, 15, 30, 45 and 1 hour of drug treatment. The efficacy of the drug was measured by observing: patient rated pain, time to pain relief, rate of pain recurrence, the need for rescue analgesia, adverse events and functional status.
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 20 |
| Maximum Age: | 60 |
More Details
| NCT Number: | NCT03780556 |
|---|---|
| Other IDs: | ASU 5418 |
| Study URL: | https://ClinicalTrials.gov/show/NCT03780556 |
Last updated: Jan 28, 2021